Screener
Prestige Consumer Healthcare PBH Business Segments
| Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | ||
|---|---|---|---|---|---|---|
| Total revenues by Business | ||||||
| International OTC Healthcare | $39.5M+6.9% | $47.07M-1.0% | $47.75M-7.1% | $43.36M-1.4% | $36.95M+6.1% | |
| North American OTC Healthcare | $226.21M+6.4% | $234.55M-5.8% | $235.7M-1.4% | $230.76M-3.8% | $212.58M-8.5% | |
| Total revenues by Product | ||||||
| Cough, Cold & Allergy | $21.31M+12.1% | —— | —— | —— | $19.01M— | |
| Dermatologicals | $33.2M+10.2% | $30.49M+4.8% | $29.64M-3.3% | $35.7M-0.4% | $30.11M-9.7% | |
| Eye & Ear Care | $32.98M+2.1% | $37.85M-19.0% | $38.6M-15.5% | $34.18M-20.1% | $32.31M-32.9% | |
| Gastrointestinal | $62.2M+7.6% | $68.35M-0.8% | $69.45M+0.7% | $64.2M+6.9% | $57.78M-0.4% | |
| Oral Care | $22.36M+3.0% | $28M+3.3% | $26.58M+15.2% | $24.77M+2.8% | $21.7M+4.5% | |
| Pain Relief | $26.8M-7.4% | —— | —— | —— | $28.93M— | |
| Wellness, Sleep & Other | $14.33M+180% | —— | —— | —— | $5.11M— | |
| Women's Health | $52.54M-3.7% | $57.05M-10.6% | $57.77M-0.6% | $56.2M-6.9% | $54.58M0.0% |
FAQ
- How does Prestige Consumer Healthcare break its business down?
- Prestige Consumer Healthcare (PBH) reports total revenues by business across 2 parts — International OTC Healthcare and North American OTC Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does Prestige Consumer Healthcare's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Prestige Consumer Healthcare's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
